08/10/2016
affects 30 million American men and women, which represents 12 percent of the U.S. adult population.
Diagnosing and treating every patient in the U.S. who has sleep apnea would produce an annual economic savings of $100.1 billion.
Frost & Sullivan calculated that the annual economic burden of undiagnosed sleep apnea among U.S. adults is approximately $149.6 billion. The estimated costs include $86.9 billion in lost productivity, $26.2 billion in motor vehicle accidents and $6.5 billion in workplace accidents. Untreated sleep apnea also increases the risk of costly health complications such as hypertension, heart disease, diabetes and depression. The report estimates that undiagnosed sleep apnea also costs $30 billion annually in increased health care utilization and medication costs related to these comorbid health risks.
A new analysis has been published that reveals the staggering cost of undiagnosed obstructive sleep apnea. The new work summarizes the results of an online survey completed by patients currently being treated for obstructive sleep apnea.